Finance

Lists
1093:HKG
CSPC Pharmaceutical Group Ltd
8,88 HKD
+0,17%
(+0,015) 1D
16 ოქტ, 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1093...
Open
9,09 HKD
High
9,19 HKD
Low
8,77 HKD
Mkt. cap
102,26 მლრ.
Avg. vol.
76,68 მლნ.
Volume
72,90 მლნ.
Dividend
3,72%
Quarterly dividend
0,08 HKD
Ex-dividend date
20 ოქტ. 2026
P/E ratio
11,64
52-wk high
10,96 HKD
52-wk low
6,53 HKD
EPS
0,76 HKD
Shares outstanding
11,52 მლრდ.
No. of employees
19 ათ.
Open
9,09 HKD
High
9,19 HKD
Low
8,77 HKD
Mkt. cap
102,26 მლრ.
Avg. vol.
76,68 მლნ.
Volume
72,90 მლნ.
Dividend
3,72%
Quarterly dividend
0,08 HKD
Ex-dividend date
20 ოქტ. 2026
P/E ratio
11,64
52-wk high
10,96 HKD
52-wk low
6,53 HKD
EPS
0,76 HKD
Shares outstanding
11,52 მლრდ.
No. of employees
19 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
1 დღის წინ
CSPC Pharma stock sits 29.91 percent below HKD 12.67 target
Profile
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province. CSPC produces both active pharmaceutical ingredient and formulations. API products include penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products. CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP. CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises. One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion. CSPC Pharma is recognized as one of China's "500 Most Valuable Chinese Brands" and "Top 500 Chinese Enterprises." Wikipedia
About CSPC Pharmaceutical Group Ltd
CEOZhang Cuilong
Employees18,6 ათ.
Founded1992
Headquarters-
SectorPharmaceutical industry
Last report
20 აგვ. 2026
Fiscal period
Q2 2026
- / -
Revenue / Est. (HKD)
14,13 მლრდ. / 10,11 მლრდ.
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in HKD
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
6,62 მლრდ.
6,11 მლრდ.
6,47 მლრდ.
12,13 მლრდ.
Cost of goods sold
2,28 მლრდ.
2,11 მლრდ.
2,20 მლრდ.
2,24 მლრდ.
Cost of revenue
2,28 მლრდ.
2,11 მლრდ.
2,20 მლრდ.
2,24 მლრდ.
Research and development expenses
1,50 მლრდ.
1,62 მლრდ.
1,40 მლრდ.
1,63 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,97 მლრდ.
1,87 მლრდ.
1,89 მლრდ.
1,89 მლრდ.
Operating expense
3,47 მლრდ.
3,49 მლრდ.
3,29 მლრდ.
3,51 მლრდ.
Total operating expenses
5,75 მლრდ.
5,60 მლრდ.
5,49 მლრდ.
5,75 მლრდ.
Operating income
869,63 მლნ.
514,71 მლნ.
973,82 მლნ.
6,38 მლრდ.
Other non operating income
645,14 მლნ.
-470,42 მლნ.
181,80 მლნ.
11,92 მლნ.
EBT including unusual items
1,18 მლრდ.
505,59 მლნ.
1,13 მლრდ.
6,40 მლრდ.
EBT excluding unusual items
1,37 მლრდ.
186,56 მლნ.
1,13 მლრდ.
6,35 მლრდ.
Income tax expense
222,47 მლნ.
165,64 მლნ.
243,25 მლნ.
825,70 მლნ.
Effective tax rate
18,78%
32,76%
21,46%
12,91%
Other operating expenses
-
-
-
-
Net income
963,54 მლნ.
370,72 მლნ.
859,79 მლნ.
5,23 მლრდ.
Net profit margin
14,56%
6,06%
13,30%
43,16%
Earnings per share
-
-
-
-
Interest and investment income
-
195,87 მლნ.
-
91,68 მლნ.
Interest expense
-104,94 მლნ.
-6,76 მლნ.
-11,01 მლნ.
-2,30 მლნ.
Net interest expenses
-104,94 მლნ.
189,12 მლნ.
-11,01 მლნ.
89,37 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,14 მლრდ.
802,06 მლნ.
1,26 მლრდ.
6,67 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები